Skip to main content
Clinical Trials/NCT02218918
NCT02218918
Completed
Not Applicable

Phase 0 Study of Comparison Between Ground Walk Training and Treadmill Walk Training in COPD Patients

PSG Hospitals1 site in 1 country40 target enrollmentJuly 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Sponsor
PSG Hospitals
Enrollment
40
Locations
1
Primary Endpoint
Quality of Life (Chronic Respiratory Questionnaire)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Pulmonary Rehabilitation became a vital part of management in COPD patients in form of activity modification, dietary and pharmacological optimisation. But access to traditional supervised aerobic (treadmill) walking is debatable fact due to economical and staffing expertise in developing countries like India. The investigators designed a randomised controlled trial to evaluate the effectiveness of ground based walking over traditional treadmill walking in improving quality of life in COPD patients.

Detailed Description

Background: COPD is increasing mortality and morbidity globally. Pulmonary rehabilitation is a promising management in COPD management. Exercise training in form of aerobic (walking, cycling) and strength training is an important part of pulmonary rehabilitation. However access to traditional supervised exercise programs is questionable debate even in developed western countries. Unsupervised ground walk programs are often told by physicians but not properly prescribed. Objective: To assess whether ground or treadmill walk is better in improving functional capacity and quality of life in COPD patients Design: Randomised controlled trial Procedure: Two arms 1) supervised ground walk training 2) supervised treadmill walk training. The intensity and progression of walk is based on 6 minute walk test. Quality of life will be gauged through Chronic respiratory questionnaire and functional capacity through 6 minute walk test. Statistical analysis: Descriptive analysis for characterisation. Normality though Kolmogorov and Variables will be compared through paired and unpaired student t tests

Registry
clinicaltrials.gov
Start Date
July 2014
End Date
October 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
PSG Hospitals
Responsible Party
Principal Investigator
Principal Investigator

Baskaran Chandrasekaran

Senior Physiotherapist

PSG Hospitals

Eligibility Criteria

Inclusion Criteria

  • stable COPD
  • Stage II - IV
  • Both genders

Exclusion Criteria

  • Cardiovascular diseases uncompensated
  • uncompensated pleural diseases
  • uncompensated liver diseases
  • Recent surgeries less than 3 weeks
  • malignancy receiving chemo and radiotherapy
  • Recent exacerbations less than 3 months

Outcomes

Primary Outcomes

Quality of Life (Chronic Respiratory Questionnaire)

Time Frame: Baseline, 6 weeks

CRQ - interviewer based

Functional Capacity (6 MINUTE WALK TEST)

Time Frame: Baseline, 6 weeks

6 minute walk test according to standardisation of ATS

Study Sites (1)

Loading locations...

Similar Trials